Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H22O7 |
| Molecular Weight | 374.3845 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(O)C=CC(C[C@@H]2COC(=O)[C@@]2(O)CC3=CC(OC)=C(O)C=C3)=C1
InChI
InChIKey=ZITBJWXLODLDRH-JLTOFOAXSA-N
InChI=1S/C20H22O7/c1-25-17-8-12(3-5-15(17)21)7-14-11-27-19(23)20(14,24)10-13-4-6-16(22)18(9-13)26-2/h3-6,8-9,14,21-22,24H,7,10-11H2,1-2H3/t14-,20-/m1/s1
| Molecular Formula | C20H22O7 |
| Molecular Weight | 374.3845 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Wikstromol is the enantiomer of nortrachelogenin, isolated from Trachelospermum asiaticum var. intermedium and Pinus palustris. Wikstromol exhibited acetylcholinesterase (AChE) inhibitory. It has been found to be active against P-388 lymphocytic leukemia growth implanted in mice. The reason for this is at present unclear, although it is possible that wikstromol is either metabolized to an active antileukemic agent by the host or else serves as a biological response modifier.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL220 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24047498 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Enantioselective synthesis of (-)-wikstromol using a new approach via malic acid. | 2001-04-06 |
|
| Antifungal, antimitotic and anti-HIV-1 agents from the roots of Wikstroemia indica. | 2000-08 |
|
| Stereoselectivity questions in the synthesis of wikstromol. | 1990-11-01 |
|
| Antitumor agents. 49 tricin, kaempferol-3-O-beta-D-glucopyranoside and (+)-nortrachelogenin, antileukemic principles from Wikstroemia indica. | 1981-09-01 |
|
| (+)Nortrachelogenin, a new pharmacologically active lignan from Wikstroemia indica. | 1979-03-01 |
|
| (+)-Nortrachelogenin, a new pharmacologically active lignan from Wikstroemia indica. | 1979-03-01 |
|
| (+)-Nortrachelogenin, A New Pharmacologically Active Lignan From Wikstroemia indica. | 1979-03 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27805400
Mice: 60 or 100 mg/30 mg of thiopental
Route of Administration:
Unknown
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10985087
Wikstromol demonstrated moderate activity against HIV-1 in vitro with IC(50)s ranger from 4.02 to 5.74 uM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:13:38 GMT 2025
by
admin
on
Mon Mar 31 22:13:38 GMT 2025
|
| Record UNII |
5HG1T9G09U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5HG1T9G09U
Created by
admin on Mon Mar 31 22:13:38 GMT 2025 , Edited by admin on Mon Mar 31 22:13:38 GMT 2025
|
PRIMARY | |||
|
61521-74-2
Created by
admin on Mon Mar 31 22:13:38 GMT 2025 , Edited by admin on Mon Mar 31 22:13:38 GMT 2025
|
PRIMARY | |||
|
479756
Created by
admin on Mon Mar 31 22:13:38 GMT 2025 , Edited by admin on Mon Mar 31 22:13:38 GMT 2025
|
PRIMARY | |||
|
DTXSID70977093
Created by
admin on Mon Mar 31 22:13:38 GMT 2025 , Edited by admin on Mon Mar 31 22:13:38 GMT 2025
|
PRIMARY |